VAS203

DRUG3 trials

Sponsors

veriNOS operations GmbH

Conditions

Renal Function Impairment in Healthy VolunteersTraumatic Brain Injury

Phase 1

Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers

CompletedNCT02992236

veriNOS operations GmbHRenal Function Impairment in Healthy Volunteers

Start: 2015-08-31End: 2016-11-30Updated: 2019-08-09

Phase 2

Phase 2 a Study to Assess Safety and Pharmacokinetics of VAS203 in Patients With Traumatic Brain Injury

CompletedNCT02012582

veriNOS operations GmbHTraumatic Brain Injury

Start: 2009-11-30End: 2012-09-30Updated: 2016-03-07

Phase 3

Efficacy of VAS203 (Ronopterin) in Patients With Moderate and Severe Traumatic Brain Injury

CompletedNCT02794168

veriNOS operations GmbHTraumatic Brain Injury

Start: 2016-06-30End: 2020-06-30Updated: 2021-10-11

Related Papers

Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebo-controlled, randomised, double blind, multi-centre study.

2020-01-1410 citations